Both in Pharmaceuticals
Werewolf Therapeutics vs iBio
Over the past year HOWL returned −24.7% and IBIO returned −52.0%; their daily moves had a correlation of 0.15.
HOWL −24.7% IBIO −52.0%Growth of $1, one year, split-adjusted
| Metric | HOWL | IBIO |
|---|---|---|
| Price | $0.9861 | $0.7687 |
| Market cap | $47.9M | $49.4M |
| Today | −10.35% | −5.52% |
| 1 month | +11.9% | −30.7% |
| 6 months | +36.4% | −51.7% |
| Year to date | +55.7% | −60.2% |
| 1 year | −36.8% | −50.1% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | 17.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.3× | 494.3× |
| Net cash | $22.0M | $88.0M |
| Dividend yield | — | — |
| Volatility (60d) | 152.6% | 65.5% |
| Short % of float | 5.9% | 6.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).